3,913
edits
Changes
Jump to navigation
Jump to search
Line 10:
Line 10: + + + − +
no edit summary
Credit: J. Miller-Jones (ICRAR) using software created by R. Hynes.
Credit: J. Miller-Jones (ICRAR) using software created by R. Hynes.
===Gene Circuits===
People from Singapore planted so called "gene circuits" into the standard lab-bacterium E.-coli and made it attack biofilms of pathogenic bacteria AND kill them. Click [http://pubs.acs.org/doi/abs/10.1021/sb400077j here] for more details.
''Image Acknowledgement'':ACS Synthetic Biology. http://pubs.acs.org/doi/abs/10.1021/sb400077j
[[File:resizdDNA genes.JPG|left|200px]]Right now a case is being heard before the United States Supreme Court on whether a gene sequence known to cause breast cancer (BRCA 1 and BRCA 2) can be patented by one company. This is one of the cases where the social and ethical implications of scientific discoveries have come to the fore. A private company has argued that since it "discovered" these genes only they could develop and administer tests for this gene. This, of course, means that many women will have no access to such potentially life-saving diagnostic strategies. Further this would hinder the progress of science itself as entities other than the patent holder would not be allowed to study or observe genes. This case is being heard by the court now and the pharmaceutical company is being opposed by public interest groups and association of scientists. For more information you can access the argument [http://www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs-v2/12-398_neither_amcu_lander.authcheckdam.pdf here].
[[File:resizdDNA genes.JPG|left|200px]]Right now a case is being heard before the United States Supreme Court on whether a gene sequence known to cause breast cancer (BRCA 1 and BRCA 2) can be patented by one company. This is one of the cases where the social and ethical implications of scientific discoveries have come to the fore. Click A private company has argued that since it "discovered" these genes only they could develop and administer tests for this gene. This, of course, means that many women will have no access to such potentially life-saving diagnostic strategies. Further this would hinder the progress of science itself as entities other than the patent holder would not be allowed to study or observe genes. This case is being heard by the court now and the pharmaceutical company is being opposed by public interest groups and association of scientists. For more information you can access the argument [http://www.americanbar.org/content/dam/aba/publications/supreme_court_preview/briefs-v2/12-398_neither_amcu_lander.authcheckdam.pdf here].
''Image Acknowledgement: http://geneed.nlm.nih.gov/index.php''
''Image Acknowledgement: http://geneed.nlm.nih.gov/index.php''